Clinical Trial Update: Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating triptorelin 0.1 mg for luteal phase support in assisted reproductive technology with embryo transfer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Triptorelin (triptorelin)

Snippet

Sponsor: Moustafa Mohammed Abouelea | Conditions: Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles | Phase 3 | Status: UNKNOWN